EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.
about
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional studyAmyotrophic lateral sclerosis mimic syndromesRecent advances in amyotrophic lateral sclerosisQuo vadis motor neuron disease?A comprehensive review of amyotrophic lateral sclerosisQuality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of NeurologyThe hidden Niemann-Pick type C patient: clinical niches for a rare inherited metabolic disease.Genetic testing in ALS: A survey of current practices.Characterization of monoclonal gammopathy in patients with amyotrophic lateral sclerosis.Characteristics of pain in amyotrophic lateral sclerosis.Discriminant ability of the Eating Assessment Tool-10 to detect aspiration in individuals with amyotrophic lateral sclerosis.Diagnostic support for selected neuromuscular diseases using answer-pattern recognition and data mining techniques: a proof of concept multicenter prospective trial.Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database.A blinded international study on the reliability of genetic testing for GGGGCC-repeat expansions in C9orf72 reveals marked differences in results among 14 laboratories.Is survival improved by the use of NIV and PEG in amyotrophic lateral sclerosis (ALS)? A post-mortem study of 80 ALS patients.Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach.The path to specialist multidisciplinary care in amyotrophic lateral sclerosis: A population- based study of consultations, interventions and costsHypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trialA quantitative method to monitor reactive oxygen species production by electron paramagnetic resonance in physiological and pathological conditions.Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study.Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor.Is the effect of non-invasive ventilation on survival in amyotrophic lateral sclerosis age-dependent?Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options.Survey of current enteral nutrition practices in treatment of amyotrophic lateral sclerosisAnd the patient said: "let me be able to breathe and dream".Noninvasive ventilation improves sleep in amyotrophic lateral sclerosis: a prospective polysomnographic study.Multidisciplinary Interventions in Motor Neuron Disease.Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review.The full spectrum of ethical issues in the care of patients with ALS: a systematic qualitative review.Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study.Family caregivers' accounts of caring for a family member with motor neurone disease in Norway: a qualitative study.Hospitalizations due to respiratory failure in patients with Amyotrophic Lateral Sclerosis and their impact on survival: a population-based cohort studyThe Awaji criteria increases the diagnostic sensitivity of the revised El Escorial criteria for amyotrophic lateral sclerosis diagnosis in a Chinese populationAttitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers.Nontraumatic spinal cord injury at the neurological intensive care unit: spectrum, causes of admission and predictors of mortality.Patient-reported problematic symptoms in an ALS treatment trial.Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.Stressing Out Hsp90 in Neurotoxic Proteinopathies.Dihuang Yinzi, a Classical Chinese Herbal Prescription, for Amyotrophic Lateral Sclerosis: A 12-Year Follow-up Case Report.
P2860
Q24600803-DCAC8037-71D4-407B-BA65-B63175913E54Q26744171-A62D4879-2B41-42E1-BEBB-C9BD4F0DA0E8Q26749521-54A8A7FB-F035-4103-9688-B0F2C3D8A671Q26750561-365D9866-69E3-4F63-B5B9-AE956C9BA3C4Q26775401-BD026C61-9A3D-41CD-B17B-59517CB1E03EQ27001213-F7DAA33F-F900-49F7-B176-6367FF4535B8Q30235362-1D9328E5-17A0-45B4-9EDA-76F1D8ACBAFDQ30236027-A0BC45E7-AA9D-4E11-80B4-4D28A6E982CEQ30316799-39422B73-591D-40FF-9FDD-BBD805DDC7EBQ30316800-F6CB275F-442B-4C32-BCF9-8FCF2B19A0B7Q30691863-90F988D3-04F7-454A-B029-A02C68A925B0Q31055021-B31B3C97-B30E-4DA4-AF60-2D93470B94BDQ31150316-728ADE8C-A820-4ABE-811D-E4BFD898713EQ33658563-C04D842C-6273-4A36-9DFB-FBC6CA15B6EEQ33719041-4428CB9E-CC2E-4F22-BFD2-2AD5D1831CD1Q33734415-B24AEB89-989F-441E-AD74-26D16FF95BE8Q33825530-58F086EB-08E9-4F11-A208-1AD07000BC2EQ34251334-563D7121-CE8E-4D36-8428-814B6925F3E6Q34413153-0FBEF22C-F8D9-42B9-B980-C0FD0B229960Q34523766-4ED81A6B-18F6-4E64-8C78-8BC04D4A31C8Q34557247-15FBDC4A-04A3-4D14-8B8D-25E9F5FFB6DAQ34739073-5F877131-7016-4634-983B-F323F3C7CF83Q34815254-B90C2E9E-CB15-4E61-A7D5-8B292F9B6DF3Q34820824-F956527A-8402-4252-B409-47F3B1319548Q35542017-947E6E02-E9FA-49C3-84C3-C73BA3574909Q35542051-277AB0DF-466C-4572-BD63-1C420F247468Q35623262-9F155A15-CE16-47E5-9B89-86B4B3158DB6Q35630224-E24E0619-BE2C-4265-9E45-9C3B10578CFEQ35724752-5FA88D8E-2973-41BA-9B19-90464BD1E63EQ35776923-2D332084-14C7-4CA9-9D05-A62FC9634081Q35877457-A9482799-98E2-4A5F-B72A-AB7BFF55B1D0Q35934699-04708CD1-187C-403A-8786-8BC24FE67050Q36181514-20136540-69C2-4E61-9694-59C212E7F4DEQ36293991-D6FDDEB2-178E-46BB-BC63-2D075D0313C7Q36346781-87BD7885-A19F-4CE8-873A-0226DD0408F1Q36667797-36AF784B-128D-46FC-BEB9-377BE61861B9Q37164599-B77BE76B-DCBE-45BB-9CAF-4C6F0680665AQ37180715-21EC617A-E594-4362-9FA0-5ABAFD946AA6Q37198079-658CEF44-7814-41F0-AA84-E98DF8F780FAQ37206849-7B8CFF3F-2A9C-4514-8FA4-110282E52E4A
P2860
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
EFNS guidelines on the clinica ...... report of an EFNS task force.
@en
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis
@nl
type
label
EFNS guidelines on the clinica ...... report of an EFNS task force.
@en
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis
@nl
prefLabel
EFNS guidelines on the clinica ...... report of an EFNS task force.
@en
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis
@nl
P2093
P2860
P50
P1476
EFNS guidelines on the clinica ...... report of an EFNS task force.
@en
P2093
Barbara Tomik
EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:
Katja Kollewe
Maria Wasner
Markus Weber
Sharon Abrahams
P2860
P304
P356
10.1111/J.1468-1331.2011.03501.X
P50
P577
2011-09-14T00:00:00Z